These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 22592422
1. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients. del Pozo-Fernández C, Pardo-Ruiz C, Sánchez-Botella C, Blanes-Castañer V, López-Menchero R, Gisbert-Sellés C, Sánchez-Jodar C, Alvarez-Avellán L. Nefrologia; 2012 May 14; 32(3):367-73. PubMed ID: 22592422 [Abstract] [Full Text] [Related]
2. Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function. Lim VC, Sum CF, Chan ES, Yeoh LY, Lee YM, Lim SC. Int J Clin Pract; 2007 Nov 14; 61(11):1829-33. PubMed ID: 17887995 [Abstract] [Full Text] [Related]
3. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. Solini A, Penno G, Bonora E, Fondelli C, Orsi E, Trevisan R, Vedovato M, Cavalot F, Cignarelli M, Morano S, Ferrannini E, Pugliese G, Renal Insufficiency and Cardiovascular Events Study Group. J Am Geriatr Soc; 2013 Aug 14; 61(8):1253-61. PubMed ID: 23889588 [Abstract] [Full Text] [Related]
4. About the discrepancies between consensus documents, clinical practice guidelines, and legal regulations in the treatment of type 2 diabetes. Martínez-Castelao A, Górriz JL, Sola E, Morillas C, Jover A, Coronel F, Navarro-González J, De Álvaro F. Nefrologia; 2012 Jul 17; 32(4):419-26. PubMed ID: 22806275 [No Abstract] [Full Text] [Related]
5. Limitations of metformin use in patients with kidney disease: are they warranted? Vasisht KP, Chen SC, Peng Y, Bakris GL. Diabetes Obes Metab; 2010 Dec 17; 12(12):1079-83. PubMed ID: 20977579 [Abstract] [Full Text] [Related]
6. Discrepancies between the summary of characteristics and the recommended use of metformin in the treatment of type 2 diabetes mellitus patients. del Pozo-Fernández C, Pardo-Ruiz C, Sánchez-Botella C, López-Menchero R. Nefrologia; 2012 Dec 17; 32(6):837-8; author reply 388-9. PubMed ID: 23169370 [No Abstract] [Full Text] [Related]
7. Establishing pragmatic estimated GFR thresholds to guide metformin prescribing. Shaw JS, Wilmot RL, Kilpatrick ES. Diabet Med; 2007 Oct 17; 24(10):1160-3. PubMed ID: 17672860 [Abstract] [Full Text] [Related]
8. Do risk factors for lactic acidosis influence dosing of metformin? Millican S, Cottrell N, Green B. J Clin Pharm Ther; 2004 Oct 17; 29(5):449-54. PubMed ID: 15482389 [Abstract] [Full Text] [Related]
9. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist. Martínez-Ramírez HR, Jalomo-Martínez B, Cortés-Sanabria L, Rojas-Campos E, Barragán G, Alfaro G, Cueto-Manzano AM. Am J Kidney Dis; 2006 Jan 17; 47(1):78-87. PubMed ID: 16377388 [Abstract] [Full Text] [Related]
10. Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Winkelmayer WC, Stedman MR, Pogantsch M, Wieninger P, Bucsics A, Asslaber M, Bauer R, Burkhardt T, Schautzer A, Brookhart MA, Pharmacoeconomics Advisory Council of the Main Association of Austrian Sickness Funds. Pharmacoepidemiol Drug Saf; 2011 Jan 17; 20(1):57-65. PubMed ID: 21182153 [Abstract] [Full Text] [Related]
11. [Proposal for the modification of metformin use in patients with chronic kidney disease]. Balogh Z, Mátyus J. Orv Hetil; 2012 Sep 30; 153(39):1527-35. PubMed ID: 23000419 [Abstract] [Full Text] [Related]
12. Metformin and other antidiabetic agents in renal failure patients. Lalau JD, Arnouts P, Sharif A, De Broe ME. Kidney Int; 2015 Feb 30; 87(2):308-22. PubMed ID: 24599253 [Abstract] [Full Text] [Related]
13. The nephrologist's role in metformin-induced lactic acidosis. Gómez-Navarro L, de Arriba G, Sánchez-Heras M, Pérez del Valle KM, Hernández-Sevillano B, Basterrechea MA, Tallón S, Torres-Guinea M, Rodríguez-Palomares JR. Nefrologia; 2011 Feb 30; 31(5):587-90. PubMed ID: 21959726 [Abstract] [Full Text] [Related]
14. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes. Aquilante CL, Zhang W, McCollum M. Curr Med Res Opin; 2007 Mar 30; 23(3):489-94. PubMed ID: 17355730 [Abstract] [Full Text] [Related]
15. The use of oral antidiabetic agents in primary care. Weekes AJ, Thomas MC. Aust Fam Physician; 2007 Jun 30; 36(6):477-80. PubMed ID: 17565410 [Abstract] [Full Text] [Related]
16. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice. Almirall J, Bricullé M, Gonzalez-Clemente JM. Nephrol Dial Transplant; 2008 Jul 30; 23(7):2436-8. PubMed ID: 18388117 [No Abstract] [Full Text] [Related]
17. Saxagliptin plus metformin combination in patients with type 2 diabetes and renal impairment. Scheen AJ. Expert Opin Drug Metab Toxicol; 2012 Mar 30; 8(3):383-94. PubMed ID: 22313172 [Abstract] [Full Text] [Related]
18. Long term patterns of use after initiation of oral antidiabetic drug therapy. Lamberts EJ, Nijpels G, Welschen LM, Hugtenburg JG, Dekker JM, Souverein PC, Bouvy ML. Pharmacoepidemiol Drug Saf; 2011 Apr 30; 20(4):351-8. PubMed ID: 21442684 [Abstract] [Full Text] [Related]
19. Hospitalization for Lactic Acidosis Among Patients With Reduced Kidney Function Treated With Metformin or Sulfonylureas. Chu PY, Hackstadt AJ, Chipman J, Griffin MR, Hung AM, Greevy RA, Grijalva CG, Elasy T, Roumie CL. Diabetes Care; 2020 Jul 30; 43(7):1462-1470. PubMed ID: 32327421 [Abstract] [Full Text] [Related]